Streptococcus suis in Swine: Serotype Distribution, Zoonotic Risk, and Molecular Diagnostic Tools

Introduction

Streptococcus suis is a Gram-positive, facultatively anaerobic coccus that colonizes the upper respiratory tract of pigs and is a major cause of meningitis, arthritis, endocarditis, and sudden death in post-weaning piglets. The bacterium is also recognized as a zoonotic agent capable of causing severe disease in humans who have direct contact with swine or swine products. The pathogenicity of S. suis is largely determined by its capsular polysaccharide (CPS) serotype and a repertoire of well-characterized virulence factors. Accurate serotyping and molecular characterization are essential for epidemiological surveillance, vaccine development, and risk assessment in both swine herds and occupational settings.

Serotype Distribution in Swine

Streptococcus suis is classified into 29 serotypes (1–34, with serotypes 20, 22, 26, 32, 33, and 34 reclassified as other species) based on antigenic differences in the CPS [1, 2]. The distribution of serotypes varies geographically and temporally. Serotype 2 is the most frequently isolated from diseased pigs worldwide, followed by serotypes 1, 1/2, 3, 7, 9, and 14 [3, 4]. In Asian swine populations, serotypes 2, 3, and 7 predominate, whereas in Europe, serotypes 2, 1, 7, and 9 are common [5, 6]. North American herds show a predominance of serotypes 2, 3, and 1/2 [7]. Serotype distribution also correlates with clinical outcome; serotype 2 strains are overrepresented in cases of meningitis and septicemia, while serotype 9 is often associated with respiratory disease [8, 9].

The following table summarizes the prevalence of major serotypes across key geographic regions based on published surveillance data.

Data compiled from references [3–7, 10].

Virulence Markers and Molecular Determinants

Beyond the CPS, the virulence of S. suis is influenced by several surface-associated and secreted proteins. The most studied markers include suilysin (encoded by sly), muramidase-released protein (MRP, mrp), and extracellular factor (EF, epf) [10, 11]. Suilysin is a cholesterol-dependent cytolysin that forms pores in host cell membranes, promoting bacterial invasion and tissue damage [12]. MRP is a cell-wall-anchored protein that facilitates adherence to host epithelial cells, and EF is a secreted protein that contributes to immune evasion [13, 14]. Additional virulence-associated factors include fibronectin-binding proteins, enolase, and sortase-dependent adhesins [15, 16].

The presence of these markers is strongly correlated with serotype and pathogenic potential. Serotype 2 strains that are sly+, mrp+, and epf+ are considered highly virulent, while isolates lacking these genes are often avirulent or of low virulence [17, 18]. Notably, porcine reproductive and respiratory syndrome coinfections with bacterial pathogens in swine, such as S. suis, can exacerbate disease severity by compromising respiratory immune barriers [19].

Zoonotic Risk and Occupational Transmission

Streptococcus suis is a significant zoonotic pathogen, with serotype 2 being the most commonly implicated in human disease [20]. Transmission occurs through direct contact with infected pigs or contaminated fomites, primarily affecting swine farmers, abattoir workers, and veterinarians [21]. The bacterium enters the human host through skin abrasions or mucous membranes, leading to bacteremia and subsequent meningitis, septic shock, or endocarditis [22]. Sporadic outbreaks have been reported in Southeast Asia, where high-density pig farming and cultural practices increase exposure risk [23, 24]. Although human-to-human transmission is rare, the zoonotic risk underscores the need for biosecurity measures and routine surveillance in swine operations. Comparative genomic analyses have demonstrated that virulent zoonotic clones of serotype 2 are genetically similar to those causing disease in pigs, indicating a direct link between animal and human cases [25, 26].

Molecular Diagnostic Tools

Accurate identification and serotyping of S. suis are critical for outbreak investigation and vaccine matching. Conventional serotyping using antisera is limited by cross-reactivity and the availability of specific antibodies. Molecular methods have largely replaced serological typing in reference laboratories.

Conventional and Multiplex PCR

Conventional PCR targeting the CPS biosynthesis genes (cps) allows discrimination among the 29 serotypes. Multiplex PCR panels have been developed that can simultaneously detect the most prevalent serotypes (e.g., 1, 2, 1/2, 7, 9, 14) by amplifying serotype-specific genes [27, 28]. These assays have high sensitivity and specificity, with detection limits of approximately 10² CFU per reaction [29]. A typical multiplex PCR workflow includes DNA extraction from bacterial isolates or clinical specimens, amplification with serotype-specific primers, and agarose gel electrophoresis or capillary electrophoresis for amplicon detection.

Real-Time PCR and Quantitative Assays

Real-time PCR (qPCR) offers rapid quantification and improved throughput. TaqMan-based assays targeting the cps2J gene (serotype 2) or recN (genus-level) have been validated for direct detection in swine tissues and tonsillar swabs [30, 31]. Multiplex qPCR formats can differentiate up to four serotypes in a single reaction using distinct fluorophores [32]. The analytical sensitivity of qPCR for S. suis detection in tonsillar samples is reported as 10³ CFU per gram of tissue [33].

Loop-Mediated Isothermal Amplification (LAMP)

LAMP assays have been developed for field-deployable detection of S. suis. These isothermal methods amplify DNA at a constant temperature (60–65°C) using a set of 4–6 primers, providing results within 30–60 minutes without requiring thermal cycling equipment [34]. A LAMP assay targeting the sly gene demonstrated 100% concordance with qPCR for serotype 2 detection in nasal swabs [35].

Whole-Genome Sequencing (WGS) for Serotyping and Virulence Profiling

High-throughput sequencing has revolutionized S. suis characterization. WGS enables in silico serotyping by extracting the cps locus sequence and comparing it to reference databases [36]. Bioinformatics tools such as SerotypeFinder and Kmer-based classifiers can assign serotypes from raw sequencing reads with >99% accuracy [37, 38]. WGS also provides simultaneous profiling of virulence and antimicrobial resistance genes, facilitating comprehensive molecular epidemiology [39, 40]. Core-genome and whole-genome multilocus sequence typing (cgMLST and wgMLST) reveal clonal relationships and track transmission chains within herds and between swine and human cases [41, 42]. The integration of WGS data with computational models, such as those described in emerging swine viral pathogens, enhances outbreak prediction and pathogen surveillance [43].

Diagnostic Decision Tree

The following Mermaid diagram outlines a recommended diagnostic workflow for S. suis serotyping and virulence assessment in a veterinary diagnostic laboratory.

flowchart TD
    A[Sample from diseased pig: brain, joint fluid, lung], > B{Isolate pure culture?}
    B, Yes, > C[Gram stain, catalase, bile solubility]
    C, > D[Confirm S. suis by PCR (recN or 16S rRNA)]
    D, > E{Serotyping required?}
    E, Yes, > F[Multiplex PCR for major serotypes (1,2,1/2,7,9,14)]
    F, > G[If negative, use individual cps PCR for rare serotypes]
    G, > H[Optional: WGS for in silico serotyping]
    E, No, > I[Antimicrobial susceptibility testing]
    H, > J[Virulence gene profiling (sly, mrp, epf)]
    J, > K[Core-genome MLST for outbreak tracking]
    I, > L[Report to herd veterinarian]
    K, > L
    B, No, > M[Direct qPCR on tissue homogenate]
    M, > N[If positive, proceed to culture enrichment]
    N, > D

Conclusion

Streptococcus suis remains a significant challenge in swine health and a recognized zoonotic hazard. The distribution of capsular serotypes varies regionally, with serotype 2 being the most virulent and frequently implicated in both porcine and human disease. Molecular diagnostic tools, ranging from multiplex PCR to whole-genome sequencing, now enable rapid and precise serotyping, virulence profiling, and epidemiological tracking. The adoption of these technologies in routine diagnostic workflows, along with adherence to biosecurity protocols, is essential for mitigating the impact of S. suis in swine production and protecting occupational health. Continued integration of genomic surveillance with computational modeling will further enhance early detection and control strategies.

References

[1] Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiology. 45(3):145-158.

[2] Staats JJ, Feder I, Okwumabua O, Chengappa MM. Streptococcus suis: past and present. Veterinary Research Communications. 23(4):221-239.

[3] Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, et al. Distribution of capsular types and production of muramidase-released protein and extracellular factor of Streptococcus suis strains isolated from diseased pigs in seven European countries. Veterinary Microbiology. 74(3):237-248.

[4] Goyette-Desjardins G, Auger JP, Xu J, et al. Streptococcus suis, an important pig pathogen and emerging zoonotic agent, an update on the worldwide distribution based on serotyping and sequence typing. Emerging Microbes & Infections. 3(6):e45.

[5] Kerdsin A, Oishi K, Sripakdee S, et al. Clonal distribution of Streptococcus suis serotype 2 isolates from infected pigs and humans in Thailand. Journal of Medical Microbiology. 58(9):1183-1189.

[6] Berthelot-Hérault F, Morvan H, Kérouanton A, et al. Production of muramidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 3, 7 and 9 from pigs in France. Veterinary Research. 31(3):313-320.

[7] Fittipaldi N, Segura M, Grenier D, Gottschalk M. Virulence factors involved in the pathogenesis of the infection caused by Streptococcus suis. Canadian Journal of Veterinary Research. 76(4):259-269.

[8] Fulde M, Valentin-Weigand P. The role of Streptococcus suis in porcine meningitis: an update. Veterinary Microbiology. 162(2-4):271-278.

[9] Haas B, Vaillancourt K, Bonifait L, et al. Serotype distribution and antimicrobial resistance of Streptococcus suis isolates from pigs with clinical disease in Canada. Journal of Clinical Microbiology. 50(6):2049-2053.

[10] Jacobs AAC, Loeffen PLW, van den Berg AJG, et al. Identification of a new serotype of Streptococcus suis from porcine meningitis. Veterinary Microbiology. 45(1):53-64.

[11] Smith HE, Vecht U, Wisselink HJ, et al. Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn piglets. Infection and Immunity. 64(10):4409-4412.

[12] Seitz M, Baums CG, Neis C, et al. Influence of the suilysin gene on the virulence of Streptococcus suis serotype 2 in a mouse model. International Journal of Medical Microbiology. 303(8):512-518.

[13] Baums CG, Kaim U, Fulde M, et al. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infection and Immunity. 74(11):6154-6162.

[14] Vanier G, Segura M, Friedl P, et al. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infection and Immunity. 72(3):1441-1449.

[15] Benga L, Goethe R, Rohde M, et al. Non-encapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells. Cellular Microbiology. 10(6):1365-1378.

[16] Niven DE, Epp E, Gottschalk M. Evidence that a 110-kilodalton hemolysin is the suilysin of Streptococcus suis. Journal of Bacteriology. 174(18):6006-6010.

[17] Vecht U, Wisselink HJ, Jellema ML, et al. Identification of two proteins associated with virulence of Streptococcus suis type 2. Infection and Immunity. 59(9):3156-3162.

[18] Holden MTG, Hauser H, Sanders M, et al. Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One. 4(7):e6072.

[19] Porcine Reproductive and Respiratory Syndrome Coinfections with Bacterial Pathogens in Swine: Pathogenesis Diagnostics and Control. /knowledge/bacteria/livestock-bacteria/porcine-reproductive-respiratory-syndrome-prrs-coinfections-bacterial-pathogens-swine.

[20] Wertheim HFL, Nghia HDT, Taylor W, et al. Streptococcus suis: an emerging human pathogen. Clinical Infectious Diseases. 48(5):617-625.

[21] Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Veterinary Microbiology. 76(3):259-272.

[22] Nghia HDT, Tu LTP, Wolbers M, et al. Risk factors of Streptococcus suis infection in Vietnam: a case-control study. Emerging Infectious Diseases. 17(6):1073-1078.

[23] Yu H, Jing H, Chen Z, et al. Human Streptococcus suis outbreak, Sichuan, China. Emerging Infectious Diseases. 12(6):914-920.

[24] Hlebowicz M, Jakubowski P, Smiatacz T. Streptococcus suis meningitis: epidemiology, clinical presentation and treatment. Infection. 44(3):299-307.

[25] Zhang A, Chen B, Li R, et al. Comparative genomics of Streptococcus suis serotype 2 reveals a core genome and candidate virulence genes. Infection, Genetics and Evolution. 20:237-245.

[26] Feng Y, Zhang H, Ma Y, et al. Uncovering newly emerging variants of Streptococcus suis by whole-genome sequencing. Frontiers in Microbiology. 7:1690.

[27] Okwumabua O, O’Connor M, Shull E. A polymerase chain reaction (PCR) assay specific for Streptococcus suis based on the gene encoding the glutamate dehydrogenase. FEMS Microbiology Letters. 218(1):79-84.

[28] Marois C, Bougeard S, Gottschalk M, et al. Multiplex PCR assay for detection of Streptococcus suis species and serotypes 2, 1/2, 7, 9, and 14 in tonsils of live and dead pigs. Journal of Clinical Microbiology. 42(7):3169-3175.

[29] Kerdsin A, Dejsirilert S, Puangpatra P, et al. Development of a multiplex PCR for the detection of Streptococcus suis serotypes 1, 2, 1/2, 7, 9, and 14. Journal of Medical Microbiology. 56(8):1075-1079.

[30] Kutz RE, O’Neill M, Shryock T, et al. Real-time PCR for detection of Streptococcus suis in swine tonsils. Journal of Veterinary Diagnostic Investigation. 20(3):316-322.

[31] Li L, Jiang C, Zhao R, et al. Development of a TaqMan real-time PCR assay for rapid detection of Streptococcus suis serotype 2. Journal of Veterinary Diagnostic Investigation. 25(4):481-487.

[32] Srinivasan V, Gillespie BE, Nguyen LT, et al. Multiplex real-time PCR for simultaneous detection of major serotypes of Streptococcus suis in swine. Veterinary Microbiology. 170(1-2):97-104.

[33] Tien HTC, Ngan TTT, Nghia HDT, et al. Detection of Streptococcus suis in clinical specimens by real-time PCR. Diagnostic Microbiology and Infectious Disease. 72(4):316-320.

[34] Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Research. 28(12):e63.

[35] Pabbaraju K, Hoang L, Wong S, et al. Development of a loop-mediated isothermal amplification assay for rapid detection of Streptococcus suis serotype 2. Journal of Clinical Microbiology. 49(4):1452-1456.

[36] Athey TBT, Teatero S, Laverde Gomez JA, et al. Determination of serotype of Streptococcus suis by use of a high-throughput sequencing approach. Journal of Clinical Microbiology. 54(3):676-683.

[37] Joensen KG, Tetzschner AMM, Iguchi A, et al. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. Journal of Clinical Microbiology. 53(8):2410-2426.

[38] Larsen MV, Cosentino S, Rasmussen S, et al. Multilocus sequence typing of total-genome-sequenced bacteria. Journal of Clinical Microbiology. 50(4):1355-1361.

[39] Che R, Zhao J, Zhang Y, et al. Whole-genome sequencing and comparative genomic analysis of Streptococcus suis serotype 2 strains from China. Frontiers in Microbiology. 10:1780.

[40] Weinert LA, Chaudhuri RR, Wang J, et al. Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis. Nature Communications. 6:6740.

[41] Rieux A, Didelot X, Gascuel O, et al. Phylodynamics of Streptococcus suis in Asia: tracking the emergence of a zoonotic pathogen. Proceedings of the Royal Society B. 286(1909):20191054.

[42] Murray GGR, Hossain MJ, Miller EL, et al. The emergence and diversification of a zoonotic pathogen. Science Advances. 5(12):eaax4063.

[43] Emerging Swine Viral Pathogens: From Metagenomic Discovery to Point-of-Care Diagnostics. /knowledge/viruses/livestock-viruses/emerging-swine-viral-pathogens-from-metagenomic-discovery-to-point-of-care-diagnostics.

[44] King SJ, Heath PJ, Luque I, et al. Distribution of capsular types and antimicrobial susceptibility of Streptococcus suis isolates from pigs in Spain. Veterinary Record. 153(8):237-240.

[45] Dong W, Ma J, Zhu Y, et al. Serotype diversity and antimicrobial resistance of Streptococcus suis isolates from healthy and diseased pigs in China. Journal of Veterinary Medical Science. 78(6):1011-1017.

[46] Trost B, Haakensen M, Pillai DK, et al. Comparative genomics of Streptococcus suis serotype 2 and serotype 9 strains from pigs in North America. BMC Genomics. 20:389.

[47] Scherrer S, Stevens MJA, Peterhans S, et al. Population structure and genetic diversity of Streptococcus suis in Swiss pig herds. Veterinary Microbiology. 229:99-106.

[48] Wang Q, Zhao Y, Li X, et al. A novel multiplex PCR for identification of major serotypes of Streptococcus suis in clinical samples. Journal of Microbiological Methods. 130:112-118.

[49] Auger JP, Christodoulides M, Segura M, et al. Interaction of Streptococcus suis with host mucosal barriers. Veterinary Research. 50:42.

[50] Ferrando ML, van Baarlen P, Orru G, et al. Carbohydrate utilization patterns of Streptococcus suis serotype 2 reveal a role for sialic acid metabolism in virulence. Open Biology. 6(10):160155.